Glucantime is an injectable antiparasitic medication, which contains meglumine antimoniate in its composition, indicated for the treatment of American cutaneous or cutaneous-mucosal Leishmaniasis and treatment of visceral Leishmaniasis or kala-azar.
This medicine is available in the SUS as an injectable solution, which must be administered in the hospital by a healthcare professional.
How to use
This medicine is available as an injectable solution and, therefore, must always be administered by a healthcare professional, and the treatment dose must be calculated by a doctor according to the person’s weight and the type of Leishmaniasis.
Generally, treatment with Glucantime is carried out for 20 consecutive days in the case of visceral Leishmaniasis and for 30 consecutive days in cases of cutaneous Leishmaniasis.
Find out more about the treatment of Leishmaniasis.
Possible side effects
Some of the most common side effects that may occur during treatment include joint pain, nausea, vomiting, muscle pain, fever, headache, decreased appetite, difficulty breathing, swelling of the face, abdominal pain and changes in the blood test. blood, especially in liver function tests.
Who shouldn’t use
Glucantime should not be used in cases of allergy to meglumine antimoniate or in patients with kidney, heart or liver failure. Furthermore, in pregnant women it should only be used after a doctor’s advice.
